VMY-1-103
A novel dansylated analog of purvalanol B, and a CDK inhibitor that inhibits cell cycle progression and proliferation in prostate and breast cancer cells more effectively than purvalanol B.
Product Specifications
CAS Number
1209002-43-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
708.27
Molecular Formula
C34H42ClN9O4S
Notes
Research use only, not for human use.
Receptor
CDK
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx495202-01 96 Tests
Human Endoplasmic Reticulum Aminopeptidase 2 (ERAP2) CLIA Kit
Ask
View Details 
abx495202-02 5x 96 Tests
Human Endoplasmic Reticulum Aminopeptidase 2 (ERAP2) CLIA Kit
Ask
View Details 
abx495202-03 10x 96 Tests
Human Endoplasmic Reticulum Aminopeptidase 2 (ERAP2) CLIA Kit
Ask
View Details 588995 96 Tests
Anti-Myosin Heavy Chain 7B, Cardiac Muscle Beta Antibody (Anti-MYH7B) BioAssayTM ELISA Kit (Rat)
Ask
View Details